Koesten, Hirschmann & Crabtree, Inc. Dyadic International Inc Transaction History
Koesten, Hirschmann & Crabtree, Inc.
- $192 Million
- Q2 2025
A detailed history of Koesten, Hirschmann & Crabtree, Inc. transactions in Dyadic International Inc stock. As of the latest transaction made, Koesten, Hirschmann & Crabtree, Inc. holds 70 shares of DYAI stock, worth $81. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70Holding current value
$81% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DYAI
# of Institutions
40Shares Held
5.02MCall Options Held
49.6KPut Options Held
0-
Bandera Partners LLC New York, NY1.38MShares$1.62 Million0.61% of portfolio
-
Chapin Davis, Inc. Baltimore, MD883KShares$1.03 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA861KShares$1.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$303,2100.0% of portfolio
-
Truist Financial Corp250KShares$292,5000.0% of portfolio
About DYADIC INTERNATIONAL INC
- Ticker DYAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,423,100
- Market Cap $33.3M
- Description
- Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...